Drug Eluting Coronary Stent System
- UID
- IMP/MD/2019/000457_6a11d97158630de4cf3efb410f3c818b_d9d13f7f5965cf310dc1755be646fc8e
- Device class
- Class D
- Brand name
- BioFreedom
- License holder
- Cartier Healthcare LLP
- Approving authority
- CDSCO
- Product information
- The BioMatrix Alpha stent is indicated for improving coronary luminal diameter for the treatment of de novo lesions in native coronary arteries with a reference diameter ranging between 2.25mm and 4.0mm. Stents with lengths 33 and 36mm are only available for artery diameters ranging between 2.5 mm and 3.5 mm.
Drug Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000457_6a11d97158630de4cf3efb410f3c818b_d9d13f7f5965cf310dc1755be646fc8e. This device is marketed under the brand name BioFreedom. The license holder is Cartier Healthcare LLP, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.